Fatal hepatitis B reactivation in a patient with islet cell tumor on octreotide and sirolimus.
作者： Emmy Ludwig , Ersilia M. DeFilippis
DOI: 10.3978/J.ISSN.2078-6891.2015.042
关键词:
摘要: Reactivation of hepatitis B viral infection (HBVr) is a known risk in cancer patients with history chronic receiving cytotoxic or immunosuppressive therapies. Patients hematologic malignancies those who have received stem cell transplantation seem to be most at but reactivation has been reported various malignancies. can present as asymptomatic liver function test abnormalities (LFTs), symptoms abdominal pain, encephalopathy, fulminant and failure. Here we report the first case patient islet tumor on octreotide sirolimus developed failure death.
amegroups.com参考文章(26)
M. Mikulska, L. Nicolini, A. Signori, G. Rivoli, V. Del Bono, A.M. Raiola, C. Di Grazia, A. Dominietto, R. Varaldo, A. Ghiso, A. Bacigalupo, C. Viscoli, Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome Clinical Microbiology and Infection. ,vol. 20, ,(2014) , 10.1111/1469-0691.12611
Ju Dong Yang, Mohit Girotra, Alejandro Restrepo, Sarah Waheed, Bart Barlogie, Andres Duarte-Rojo, Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance. Annals of Hepatology. ,vol. 13, pp. 461- 465 ,(2014) , 10.1016/S1665-2681(19)30855-5
Winnie Yeo, Paul K.S. Chan, Sheng Zhong, Wing M. Ho, Joyce L. Steinberg, John S. Tam, Pun Hui, Nancy W.Y. Leung, Benny Zee, Philip J. Johnson, Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors Journal of Medical Virology. ,vol. 62, pp. 299- 307 ,(2000) , 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0
Raquel Bissacotti Steglich, Luana Pizarro Meneghello, André Vicente Esteves de Carvalho, Hugo Cheinquer, Fernanda Melo Muller, Flávia Pereira Reginatto, The use of ustekinumab in a patient with severe psoriasis and positive HBV serology Anais Brasileiros De Dermatologia. ,vol. 89, pp. 652- 654 ,(2014) , 10.1590/ABD1806-4841.20143013
Xing-Bin Dai, Xue-Mei Sun, Xue-Jun Zhu, Reactivation of hepatitis B virus 40 months after discontinuation of rituximab maintenance treatment and 5 months after cessation of entecavir administration Clinics and Research in Hepatology and Gastroenterology. ,vol. 39, pp. e39- e40 ,(2015) , 10.1016/J.CLINRE.2014.11.005
Robert P. Perrillo, Robert Gish, Yngve T. Falck-Ytter, American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy Gastroenterology. ,vol. 148, pp. 215- 219 ,(2015) , 10.1053/J.GASTRO.2014.10.038
Jeremy S. Abramson, Raymond T. Chung, Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma. JAMA. ,vol. 312, pp. 2505- 2507 ,(2014) , 10.1001/JAMA.2014.16095
Rosa Pérez-Grande, Nieves Gutiérrez-Zufiaurre, Santiago Muñoz-Criado, Ana M. Blázquez de Castro, Lourdes Vázquez López, Francisco González San Martín, Jose Angel García Rodríguez, Juan Luis Muñoz Bellido, Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion☆ Diagnostic Microbiology and Infectious Disease. ,vol. 64, pp. 80- 82 ,(2009) , 10.1016/J.DIAGMICROBIO.2009.01.007
Meijun Long, Weijuan Jia, Shunrong Li, Liang Jin, Jiannan Wu, Nanyan Rao, Huiyi Feng, Kai Chen, Heran Deng, Fengtao Liu, Fengxi Su, Erwei Song, None, A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy? Breast Cancer Research and Treatment. ,vol. 127, pp. 705- 712 ,(2011) , 10.1007/S10549-011-1455-9
Yutaka Okagawa, Kohichi Takada, Hiroyuki Hisai, Yutaka Koshiba, Hironori Wada, Etsu Miyazaki, Yusuke Kanari, Yutaka Kawano, Satoshi Iyama, Tsuyoshi Hayashi, Tsutomu Sato, Yasushi Sato, Koji Miyanishi, Masayoshi Kobune, Rishu Takimoto, Junji Kato, None, Successful treatment with entecavir for reactivation of hepatitis B virus following systemic chemotherapy in a hepatitis B surface antigen-negative patient with colorectal cancer. Internal Medicine. ,vol. 53, pp. 1759- 1762 ,(2014) , 10.2169/INTERNALMEDICINE.53.1970